Conclusions Administration of hydroxychloroquine did not result in a significantly higher probability of negative conversion than standard of care alone in patients admitted to hospital with mainly persistent mild to moderate covid-19. Adverse events were higher in hydroxychloroquine recipients than in non-recipients.
Small sample, but an actual RCT and published in the BMJ a peer reviewed top flight journal. We can't say for certain that Hydroxychloroquine is useless or useful, but the evidence is coalescing around the useless outcome. There are more RCTs coming out soon, so we'll see. I'm keeping an open mind. I don't care if a drug is being touted by Kim Jong Il, if an RCT shows its effective against Covid-19 I'm all for mass usage.
Come on Minnesota, publish this study, estimated completion date was May, 14th:
FYI on RCTs:


Comment